Back to Urology
Urologyv2012Evidence-Based

Prostate Health Index (phi)

The Beckman Coulter Prostate Health Index combines total PSA, free PSA and [-2]proPSA: phi = (p2PSA / fPSA) x sqrt(tPSA). Validated for men >=50 with PSA 4-10 ng/mL and non-suspicious DRE.

Clinical Input Parameters

Range: 2 — 10
Range: 0.1 — 10
Range: 1 — 5000
Range: 50 — 100
Clinical Assessment
Awaiting Parameters
phi
—index
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Prostate Health Index (phi) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within urology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

phi = (p2PSA [pg/mL] / fPSA [ng/mL]) x sqrt(tPSA [ng/mL]). NOTE the intentional unit mix: p2PSA in pg/mL, fPSA and tPSA in ng/mL.

Clinical Pearls & Practice Notes

  • Unit trap guarded: p2PSA must be pg/mL while fPSA/tPSA are ng/mL (1000x) — enforced by parameter units.
  • In the pivotal trial a phi of 27.0 gave 31% specificity at 90% sensitivity; risk rises continuously with phi.
  • Valid only for age >=50, tPSA 2-10 ng/mL, non-suspicious DRE; values outside the validated window are rejected.

Evidence & Literature Citations

  1. Catalona WJ, Partin AW, Sanda MG, et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol. 2011;185(5):1650-1655.
  2. FDA approval 2012: phi for men >=50 years, tPSA 4-10 ng/mL, non-suspicious DRE.

Score Interpretation Ranges

Below operating point0 – 27 pts

phi <27

At/above operating point27 – 1000000000 pts

phi >=27

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.